|6 Months Ended|
Jun. 30, 2023
|Stockholders’ Equity [Abstract]|
NOTE 6 – STOCKHOLDERS’ EQUITY
The Company had 26,143,407 and 26,698,688 shares of its Common Stock issued and outstanding at June 30, 2023 and 2022, respectively.
Common Stock Issuances for the Three and Six Months Ended June 30, 2023
During the three and six months ended June 30, 2023, the Company issued 16,667 and 100,001 shares of common stock, respectively, due to the vesting of restricted stock units (“RSUs”), and recognized approximately $24,000 and $48,000, respectively, of stock-based compensation expense related to its outstanding restricted stock units. Stock-based compensation expense related to the Company’s restricted stock units is recognized within selling, general and administrative expense.
As of June 30, 2023, remaining unamortized RSU stock-based compensation expense was approximately $142,000.
The Company did not grant any RSUs or restricted stock during the three and six months ended June 30, 2023.
The entire disclosure for equity.
Reference 1: http://www.xbrl.org/2003/role/disclosureRef